European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The company’s shares closed last Friday at p1,405. ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The company’s shares opened today at p1,392.50. According ...

Get Our Latest Stock Report on GSK GSK Stock Up 0.8 % GSK opened at $35.35 on Friday. GSK plc has a 1-year low of $31.72 and a 1-year high of $45.92. The firm’s 50 day simple moving average is ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...

Teva Pharmaceutical Industries Ltd. ADR-0.62% $20.28B ...

Jan. 29, Marist University celebrated their official designation change, along with a new logo and commercial. Here's what to ...

Blackstone (BX.N), opens new tab is in talks to buy a sizeable stake in a New York City 50-story office building from institutional investors of JPMorgan Asset Management, two sources familiar ...

MVRDV's Downtown One Tirana, Albania's tallest building, is also expected to make ... The project was unveiled at Bharat Mobility Global Expo 2025 in New Delhi. Beijing's Economic-Technological ...